According to the research report titled ‘Global Vaccines Market: Industry Size, Growth, Analysis and Forecast to 2025’, available with Market Study Report, global vaccines market is expected to surpass a valuation of USD 48 billion by the year 2025.
 

The research report on global vaccines market offers critical information regarding the major development trends, challenges & restraints, and other expansion trends influencing the growth matrix of this business vertical. The document also offers up-to-date information regarding the current market situation and analyzes upcoming trends in order to ensure high quality decisions during investment assessment.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2060552/
 

The major vaccines analyzed by this research report include Imavune, Anflu, BiliveIn Live, Ixiaro, Bio Thrax, Flumist/Fluenz, Jebik V, Dukoral, HeaLive, Varicella (MTP), Mearubik, Tetrabik, EasySix, Biken Ha, Infanrix,Ticovac, Pediarix, , Rotarix, Zostavax, Pentacel, Pentaxim, Imovax, Hexaxim, Shingrix, Trumenba, Cervarix, Menveo, Synflorix Rotateq, Bexsero, Boostrix, Adacel, M-M-R®II, Priorix, Priorix Tetra, Varilrix, Havrix/Twinrix/Energix-B, Fluarix/FluLaval, Pneumovax 23, Proquad, Menactra, Varivax, Flublok, Fluzone, Vacigrip, Gardasil/ Gardasil 9, and Prevnar/ Prevnar 13.
 

Apart from this, the document also scrutinizes the competitive landscape of global vaccines market by evaluating the strategic approaches deployed by leading companies in order to gain a competitive edge. It also highlights the market share, product innovations, mergers & acquisitions, collaborations, and licensing agreements deployed by the top manufacturers.
 

The major companies operating in global vaccines market are Biological E. Limited, Serum Institute of India, Bharat Biotech International Limited, Panacea Biotec, Sinovac Biotech Ltd., Bavarian Nordic A/S, Seqirus, Valneva SE, Astellas Pharma Inc., Emergent BioSolutions Inc., Mitsubishi Tanabe Pharma Corporation, AstraZeneca plc, Pfizer Inc., Merck Group, GlaxoSmithKline plc, and Sanofi S.A. among others.